替马沙星纸片效价及药敏试验暂行解释标准。
Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.
作者信息
Barry A L, Jones R N
机构信息
Clinical Microbiology Institute, Tualatin, Oregon 97062.
出版信息
J Clin Microbiol. 1989 Dec;27(12):2861-3. doi: 10.1128/jcm.27.12.2861-2863.1989.
Abstract
Temafloxacin disk susceptibility test criteria were evaluated by testing 697 bacterial isolates. Either 5- or 10-micrograms disks could be used satisfactorily. A 5-micrograms temafloxacin disk with zone size breakpoints of less than or equal to 12 mm for resistance (MIC, greater than 4.0 micrograms/ml) and greater than 16 mm for susceptibility (MIC, less than or equal to 2.0 micrograms/ml) is recommended.
摘要
通过检测697株细菌分离株对替马沙星纸片药敏试验标准进行了评估。5微克或10微克的纸片均可令人满意地使用。推荐使用5微克的替马沙星纸片，其抑菌圈大小的判断标准为：耐药（MIC，大于4.0微克/毫升）时小于或等于12毫米，敏感（MIC，小于或等于2.0微克/毫升）时大于16毫米。
相似文献
1
Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.替马沙星纸片效价及药敏试验暂行解释标准。
J Clin Microbiol. 1989 Dec;27(12):2861-3. doi: 10.1128/jcm.27.12.2861-2863.1989.
2
In vitro activity of the aryl-fluoroquinolones A-56619 and A-56620 and evaluation of disk susceptibility tests.
Eur J Clin Microbiol. 1986 Feb;5(1):18-22. doi: 10.1007/BF02013455.
3
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.流感嗜血杆菌对CI-960、氟罗沙星和替马沙星药敏试验的解释标准。
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):462-5. doi: 10.1007/BF01961865.
4
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.CI-960（PD127391，AM-1091）、氟罗沙星、洛美沙星和替马沙星对淋病奈瑟菌药敏试验的解释标准，包括在GC琼脂培养基中的药物稳定性。
J Clin Microbiol. 1992 May;30(5):1170-3. doi: 10.1128/jcm.30.5.1170-1173.1992.
5
6
Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.司帕沙星纸片扩散法药敏试验的暂行解释标准。
J Clin Microbiol. 1993 Aug;31(8):2236-7. doi: 10.1128/jcm.31.8.2236-2237.1993.
7
Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks.使用5微克纸片进行CI-960（AM-1091，PD127391）纸片扩散试验的解释标准。
Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):379-81. doi: 10.1016/0732-8893(92)90029-s.
8
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
Diagn Microbiol Infect Dis. 1987 Mar;6(3):185-92. doi: 10.1016/0732-8893(87)90011-3.
9
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.替马沙星、托氟沙星（A-61827）及其他五种氟喹诺酮类药物的体外活性
J Antimicrob Chemother. 1989 Apr;23(4):527-35. doi: 10.1093/jac/23.4.527.
10
Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).优化哌拉西林与他唑巴坦（YTR 830）体外试验的研究。
Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):495-510. doi: 10.1016/0732-8893(89)90084-9.
引用本文的文献
1
Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests.左氧氟沙星纸片效价及药敏试验的暂定解释标准。
J Clin Microbiol. 1993 Jul;31(7):1924-6. doi: 10.1128/jcm.31.7.1924-1926.1993.
2
Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.使用预测性检测板开发用于头孢哌酮-舒巴坦扩散试验的新型试纸条。
Antimicrob Agents Chemother. 1992 Feb;36(2):394-400. doi: 10.1128/AAC.36.2.394.
3
Interpretive criteria for CI-960, fleroxacin and temafloxacin susceptibility tests with Haemophilus influenzae.流感嗜血杆菌对CI-960、氟罗沙星和替马沙星药敏试验的解释标准。
Eur J Clin Microbiol Infect Dis. 1992 May;11(5):462-5. doi: 10.1007/BF01961865.
4
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.CI-960（PD127391，AM-1091）、氟罗沙星、洛美沙星和替马沙星对淋病奈瑟菌药敏试验的解释标准，包括在GC琼脂培养基中的药物稳定性。
J Clin Microbiol. 1992 May;30(5):1170-3. doi: 10.1128/jcm.30.5.1170-1173.1992.
本文引用的文献
1
Proposed disk diffusion susceptibility criteria for ofloxacin.氧氟沙星的纸片扩散法药敏试验推荐标准。
J Clin Microbiol. 1985 Aug;22(2):310-1. doi: 10.1128/jcm.22.2.310-311.1985.
2
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.依诺沙星的体外抗菌活性评估：与其他口服吸收抗菌剂的比较、提议的纸片扩散试验解释标准及质量控制限度。
Diagn Microbiol Infect Dis. 1985 May;3(3):213-21. doi: 10.1016/0732-8893(85)90033-1.
3
Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.阿米氟沙星与其他五种氟喹诺酮类抗菌剂的体外活性比较及纸片药敏试验的初步标准。
Eur J Clin Microbiol. 1987 Apr;6(2):179-82. doi: 10.1007/BF02018204.
4
Tentative disk diffusion susceptibility interpretive criteria for pefloxacin.培氟沙星纸片扩散法药敏试验初步解释标准。
J Clin Microbiol. 1986 Sep;24(3):448-50. doi: 10.1128/jcm.24.3.448-450.1986.
5
Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.盐酸替马沙星（A-62254）与两种氟喹诺酮类对照品的抗菌活性比较
Antimicrob Agents Chemother. 1987 Nov;31(11):1768-74. doi: 10.1128/AAC.31.11.1768.
6
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.新型二氟喹诺酮抗菌剂替马沙星的体外活性
Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):58-63. doi: 10.1007/BF01962176.
7
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria.
Diagn Microbiol Infect Dis. 1987 May;7(1):29-35. doi: 10.1016/0732-8893(87)90066-6.
8
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.替马沙星、托氟沙星（A-61827）及其他五种氟喹诺酮类药物的体外活性
J Antimicrob Chemother. 1989 Apr;23(4):527-35. doi: 10.1093/jac/23.4.527.
9
Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.氧氟沙星微量稀释法和纸片扩散法药敏试验的质量控制参数以及纸片扩散法解释标准的确认。
J Clin Microbiol. 1989 Jan;27(1):49-52. doi: 10.1128/jcm.27.1.49-52.1989.
Zotero 插件